Conventional heart failure therapy in cardiac ATTR amyloidosis

Adam Ioannou(MACOM (United States)), Marianna Fontana(Johnson & Johnson (United States)), Aviva Petrie(Eastman Dental Hospital), Mark C. Petrie(Copenhagen University Hospital), Helen J. Lachmann(Royal Free London NHS Foundation Trust), Ashutosh Wechelakar(MACOM (United States)), Michele Emdin(Scuola Superiore Sant'Anna), Lucia Venneri(MACOM (United States)), John J.V. McMurray(Western Infirmary), Nick Freemantle(University College London), Philip N. Hawkins(The Royal Free Hospital), Ruta Virsinskaite(The Royal Free Hospital), Rishi Patel(MACOM (United States)), Julian D. Gillmore(Alnylam Pharmaceuticals (United States)), Carol Whelan(Boston University), Alun D. Hughes(University of Aberdeen), Steven Law(The Royal Free Hospital), Yousuf Razvi(MACOM (United States)), Aldostefano Porcari(University of Trieste), Muhammad U. Rauf(MACOM (United States)), Tushar Kotecha(Royal Society), Francesco Bandera(IRCCS Policlinico San Donato), Ana Martinez–Naharro(Children's Cancer and Leukaemia Group), Stefano Filisetti(IRCCS Policlinico San Donato), Paolo Massa(MACOM (United States)), G. Cabras(The Royal Free Hospital), Roos Eline Bolhuis(The Royal Free Hospital), Anita Jiang(The Royal Free Hospital), Daniel Knight(MACOM (United States))
European Heart Journal
May 22, 2023
Cited by 136


Related Papers